Follow

Submissions from 2012

PDF

Onset of alcohol or substance use disorders following treatment for adolescent depression., John Curry, Susan Silva, Paul Rohde, Golda Ginsburg, Betsy Kennard, Christopher Kratochvil, Anne Simons, Jerry Kirchner, Diane May, Taryn Mayes, Norah Feeny, Anne Marie Albano, Sarah Lavanier, Mark Reinecke, Rachel Jacobs, Emily Becker-Weidman, Elizabeth Weller, Graham Emslie, John Walkup, Elizabeth Kastelic, Barbara Burns, Karen Wells, and John March

PDF

The evidence-based pharmacological treatment of paediatric ADHD., Brigette S. Vaughan, John S. March, and Christopher J. Kratochvil

Submissions from 2011

PDF

Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials., Timothy E. Wilens, Laura M. Gault, Ann Childress, Christopher J. Kratochvil, Lindsey Bensman, Coleen M. Hall, Evelyn Olson, Weining Z. Robieson, Tushar S. Garimella, Walid M. Abi-Saab, George Apostol, and Mario D. Saltarelli

Submissions from 2009

PDF

An exploratory analysis of the impact of family functioning on treatment for depression in adolescents., Norah C. Feeny, Susan G. Silva, Mark A. Reinecke, Steven McNulty, Robert L. Findling, Paul Rohde, John F. Curry, Golda S. Ginsburg, Christopher J. Kratochvil, Sanjeev M. Pathak, Diane E. May, Betsy D. Kennard, Anne D. Simons, Karen C. Wells, Michele Robins, David Rosenberg, and John S. March

PDF

Dysfunctional attitudes scale perfectionism: a predictor and partial mediator of acute treatment outcome among clinically depressed adolescents., Rachel H. Jacobs, Susan G. Silva, Mark A. Reinecke, John F. Curry, Golda S. Ginsburg, Christopher J. Kratochvil, and John S. March

PDF

Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes., Betsy D. Kennard, Susan G. Silva, Simon Tonev, Paul Rohde, Jennifer L. Hughes, Benedetto Vitiello, Christopher J. Kratochvil, John F. Curry, Graham J. Emslie, Mark Reinecke, and John March

PDF

Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study., Christopher J. Kratochvil, Diane E. May, Susan G. Silva, Vishal Madaan, Susan E. Puumala, John F. Curry, John Walkup, Hayden Kepley, Benedetto Vitiello, and John S. March

Submissions from 2008

PDF

Antidepressant prescribing practices for the treatment of children and adolescents., Supriya K. Bhatia, Amy J. Rezac-Elgohary, Benedetto Vitiello, Michael A. Sitorius, Bruce A. Buehler, and Christopher J. Kratochvil

PDF

Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy., Christopher J. Kratochvil, Denái R. Milton, Brigette S. Vaughan, and Laurence L. Greenhill

PDF

Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring., Julie M. Zito, Albert T. Derivan, Christopher J. Kratochvil, Daniel J. Safer, Joerg M. Fegert, and Laurence L. Greenhill

Submissions from 2007

PDF

Emotional expression during attention-deficit/hyperactivity disorders treatment: initial assessment of treatment effects., Christopher J. Kratochvil, D. Faries, Brigette S. Vaughan, A. Perwien, J. Busner, K. Saylor, S. Kaplan, C. Buermeyer, and R. Swindle

PDF

A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder., Christopher J. Kratochvil, Brigette S. Vaughan, Michelle L. Mayfield-Jorgensen, John S. March, Scott H. Kollins, Desiree W. Murray, Hima Ravi, Laurence L. Greenhill, Lisa A. Kotler, Natalya Paykina, Patricia Biggins, and Julie Stoner

PDF

Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment., Thomas J. Spencer, Christopher J. Kratochvil, R. Bart Sangal, Keith E. Saylor, Charles E. Bailey, David W. Dunn, Daniel A. Geller, Charles D. Casat, Robert S. Lipetz, Rakesh Jain, Jeffrey H. Newcorn, Dustin D. Ruff, Peter D. Feldman, Amanda J. Furr, and Albert J. Allen

Submissions from 2006

PDF

Treatment for Adolescents with Depression Study (TADS): safety results., Graham Emslie, Christopher J. Kratochvil, Benedetto Vitiello, Susan Silva, Taryn Mayes, Steven McNulty, Elizabeth Weller, Bruce Waslick, Charles Casat, John Walkup, Sanjeev Pathak, Paul Rohde, Kelly Posner, John March, The Columbia Suicidality Classification Group, and Tads Team

PDF

Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?, Christopher J. Kratochvil, Benedetto Vitiello, John Walkup, Graham Emslie, Bruce D. Waslick, Elizabeth B. Weller, William J. Burke, and John S. March

PDF

Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes?, Amy R. Perwien, Christopher J. Kratochvil, Douglas E. Faries, Brigette S. Vaughan, Thomas Spencer, and Ronald T. Brown

Submissions from 2001

PDF

An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder., Christopher J. Kratochvil, Daryl Bohac, Martin Harrington, Natalie Baker, Diane E. May, and William J. Burke